#USA #Center Valley #Olympus #SecureFlex #Biopsy Device

Olympus Introduces the SecureFlex™ FNB Device

On January 28, 2026, Olympus Corporation of the Americas, a leading global MedTech firm, unveiled the U.S. launch of its innovative SecureFlex™ Fine Needle Biopsy (FNB) device. Designed for ultrasound-guided procedures, this disposable tool significantly enhances precision in tissue sampling, particularly in diagnosing serious conditions such as pancreatic cancer.

A Leap Forward in Biopsy Techniques

The SecureFlex™ FNB needle represents a substantial advancement in the field of diagnostic medicine. This device is engineered to facilitate the collection of large, intact tissue samples from traditionally hard-to-reach lesions, including those located in the pancreatic head and uncinate process. The device is offered in various sizes—19G, 22G, and 25G—allowing physicians to select the most suitable option for their specific needs.

Olympus is showcasing the SecureFlex™ FNB needle during the upcoming Cedars-Sinai Endoscopy Symposium (January 28-31) and the Orlando Live Endoscopy 2026 (February 4-6), where it aims to highlight the benefits of this advanced medical tool to healthcare professionals.

The Importance of Precision in Biopsy

Precision is critical in biopsy procedures, especially when aiming for diagnostic accuracy. As highlighted by Christian Hagie, Vice President of the GI EndoTherapy Business Unit, “Gastroenterologists demand precision and reliability when performing biopsies for diagnostic purposes. The SecureFlex™ EUS-FNB needle has been meticulously designed to provide a dependable biopsy solution that allows efficient access to complex anatomical structures.” This design aids in gathering adequate samples, even in challenging cases, ensuring that healthcare providers can make well-informed decisions based on the results.

Innovative and Functional Design

The innovative features of the SecureFlex™ FNB needle contribute to its effectiveness:

• - Dual-Beveled Raptor™ Tip: This unique design features an outer distal cutting surface for smooth tissue puncture, while the inner proximal cutting surface helps gather larger tissue samples into the needle. This enhancement is particularly beneficial in maintaining cellular architecture for accurate diagnostics.
• - Nitinol Construction: This material choice enables the needle to resist deformation in tortuous anatomical pathways, ensuring straightness even after multiple passes.
• - Multi-layer Sheath: This layer facilitates effortless handling to ensure smooth operations during procedures.
• - Houndstooth Patterned Dimpling: This design allows for improved ultrasound visibility, aiding in the precise guidance needed during biopsies.

As cancer treatment options evolve, particularly for pancreatic cancer, the demand for high-quality tissue samples is growing. The SecureFlex™ FNB needle is key to meeting this need, as it provides the quality and size of samples necessary for effective treatment decisions.

Complementary Technologies

The SecureFlex™ EUS-FNB needle is part of a broader suite of GI technologies from Olympus that includes the EU-ME3 Ultrasound Processor. This advanced device delivers high-quality imaging comparable to top-tier ultrasound centers, but in a compact format. The EU-ME3 enhances diagnostic imaging capabilities and ultrasound-guided interventions in hepatobiliary and pancreatic procedures, thus expanding the frontiers of endosonography.

Understanding the Risks

While the benefits of the SecureFlex™ FNB needle are significant, it is essential to address potential risks associated with EUS-guided fine needle biopsies. Complications may vary from infection, bleeding, and perforation to tumor seeding, particularly with cystic lesions. Olympus provides comprehensive training and support to healthcare professionals to mitigate these risks and improve patient outcomes.

In conclusion, the introduction of the SecureFlex™ FNB device by Olympus is a vital step towards enhancing diagnostic capabilities in gastroenterology. With its precision-engineered features, the device is set to improve the standard of care in the early detection and diagnosis of pancreatic cancer and other serious conditions.